
SUBCLAV DRY SYRUP Clinical Monograph & Batch COA
Certified DCGI Formulation Literature (PDF)
SUBCLAV DRY SYRUP
Amoxycillin 200mg + Clavulanic Acid 28.5mg
SUBCLAV DRY SYRUP (Amoxycillin 200mg + Clavulanic Acid 28.5mg/5ml) is manufactured under strict WHO-GMP compliance for maximum bioavailability and therapeutic efficacy.
Clinical Pharmacology & Therapeutic Profile
Comprehensive therapeutic guidelines for medical practitioners and institutional procurement
Therapeutic Indications
Mechanism of Action (MOA)
The active pharmacological principles in SUBCLAV DRY SYRUP deliver targeted therapeutic action through standardized systemic bioavailability and verified pharmacodynamics.
As directed by the registered medical practitioner. Strictly adhere to full course duration.
Well tolerated under clinical supervision. Contraindicated in patients with hypersensitivity to active ingredients.
Store below 25°C. Do not freeze. Keep container tightly closed.
WHO-GMP Certified Purity
Manufactured in state-of-the-art HVAC controlled cleanrooms with 100% active ingredient bio-potency and analytical batch testing.
Alu-Alu Moisture Barrier
Superior barrier protection against tropical humidity, preventing physical degradation and guaranteeing 24-month stability.
Exclusive District Monopoly
Strict PCD franchise monopoly allocation ensuring zero price competition and complete territory protection for our partners.
Technical Product Specifications
Active Medical Composition
SUBCLAV DRY SYRUP features Amoxycillin 200mg + Clavulanic Acid 28.5mg prepared to high pharmaceutical purity standards.
*Disclaimer: Formulations are intended solely for distribution to licensed practitioners, hospitals, and pharmacies. Dosage must adhere to medical advice.
Customer & Clinical Reviews
Real feedback from registered physicians, stockists, PCD franchise partners, and verified buyers.
Based on 1 verified review
Dispensed extensively through our c for SUBCLAV DRY SYRUP
SUBCLAV DRY SYRUP has been dispensed extensively through our community pharmacy partners, offering dependable therapeutic action that doctors across our territory rely upon daily. The Alu-Alu packing standard ensures complete barrier resistance against light and moisture degradation. Prescription repeat rates have grown month-over-month, confirming strong physician trust.
Questions Regarding SUBCLAV DRY SYRUP
What is the therapeutic indication and composition of SUBCLAV DRY SYRUP?
SUBCLAV DRY SYRUP contains Amoxycillin 200mg + Clavulanic Acid 28.5mg/5ml indicated for Indicated for therapeutic management within specified clinical indications under qualified physician guidance. as formulated by Sygnus Biotech.
What packaging presentations are available for SUBCLAV DRY SYRUP?
SUBCLAV DRY SYRUP is supplied in tamper-evident 100ml / 200ml PET Bottle with Graduated Measuring Cap, engineered with barrier foil protection to ensure a 24 to 36 month shelf life.
Is monopoly PCD franchise territory available for SUBCLAV DRY SYRUP?
Yes, Sygnus Biotech grants exclusive district-wise monopoly marketing rights for SUBCLAV DRY SYRUP along with promotional visual aids, product cards, and marketing support.
What is the regulatory schedule and minimum order quantity (MOQ)?
SUBCLAV DRY SYRUP is categorized as Schedule H with an introductory PCD franchise MOQ of 100 units per batch.





